about
Sporadic ALS is not associated with VAPB gene mutations in Southern ItalyAssisting persons with advanced amyotrophic lateral sclerosis in their leisure engagement and communication needs with a basic technology-aided program.Axonal damage in multiple sclerosis plaques: a combined magnetic resonance imaging and 1H-magnetic resonance spectroscopy study.Laser evoked potentials in amyotrophic lateral sclerosis.Cortical thinning and clinical heterogeneity in amyotrophic lateral sclerosis.Lesion load may predict long-term cognitive dysfunction in multiple sclerosis patients.CHCH10 mutations in an Italian cohort of familial and sporadic amyotrophic lateral sclerosis patients.Influence of Interferon beta treatment on quality of life in multiple sclerosis patientsIncidence of amyotrophic lateral sclerosis in southern Italy: a population based study.C9ORF72 hexanucleotide repeat expansions in the Italian sporadic ALS population.Frontal assessment battery for detecting executive dysfunction in amyotrophic lateral sclerosis without dementia: a retrospective observational studyLocalised 1H-MR spectroscopy for metabolic characterisation of diffuse and focal brain lesions in patients infected with HIV.HFE p.H63D polymorphism does not influence ALS phenotype and survival.Gangliosides and the Guillain-Barré syndrome.Clinical and magnetic resonance imaging predictors of disease progression in multiple sclerosis: a nine-year follow-up study.Isoelectric focusing and crossed immunoelectrofocusing of cerebrospinal fluid proteins in neurological disorders.Proton MR spectroscopy in idiopathic spasmodic torticollis.Amyotrophic lateral sclerosis: a new missense mutation in the SOD1 gene.Sniff nasal inspiratory pressure as a prognostic factor of tracheostomy or death in amyotrophic lateral sclerosis.Prospective study of multiple sclerosis with early onset.Isoelectric focusing (IF) of cerebrospinal fluid (CSF) proteins: II) preliminary results in brain atrophies of various etiologies.Course and prognosis in early-onset MS: comparison with adult-onset forms.Identification of HIV-associated progressive multifocal leukoencephalopathy: magnetic resonance imaging and spectroscopy.Multiple sclerosis in childhood: clinical features of 149 cases.Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for ALS.[Current prospects of cerebrospinal fluid diagnostics. II. Spectrophotometry]Elevated plasma homocysteine levels in patients with amyotrophic lateral sclerosis.Correlation between fatigue and brain atrophy and lesion load in multiple sclerosis patients independent of disability.Metabolic changes in neuronal migration disorders: evaluation by combined MRI and proton MR spectroscopy.First mutation in the nuclear localization signal sequence of spastin protein identified in a patient with hereditary spastic paraplegia.Interleukin-6 levels in the cerebrospinal fluid and serum of patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.Whole-brain and regional brain atrophy in amyotrophic lateral sclerosis.A case of Landau-Kleffner syndrome secondary to inflammatory demyelinating disease.Adult-onset Rasmussen's encephalitis: anatomical-electrographic-clinical features of 7 Italian cases.Proton magnetic resonance spectroscopy in primary blepharospasm.Acute changes in blood-CSF barrier permselectivity to serum proteins after intrathecal methotrexate and CNS irradiation.Proton magnetic resonance spectroscopy in Parkinson's disease and atypical parkinsonian disorders.Heterogeneous models for blood-cerebrospinal fluid barrier permeability to serum proteins in normal and abnormal cerebrospinal fluid/serum protein concentration gradients.Age-related gadolinium-enhancement of MRI brain lesions in multiple sclerosis.Brain atrophy evolution and lesion load accrual in multiple sclerosis: a 2-year follow-up study.
P50
Q21245641-06351FE4-8D5E-4BA1-B194-4C812D2F85F2Q30379572-BB3E486F-E874-41B6-A107-E24F84FEC830Q31800788-0BCA2FD9-23A9-46B2-800B-5D067BC04FE6Q33511085-8842EF30-DD96-4603-8AD3-90519C574EE7Q35053698-3FA970C7-66A8-4F4B-B436-4E7AFC19B4EDQ35224690-E9DFD2F3-3145-4949-9D6E-0ED1108B1A77Q35236293-8203AC6F-C7CD-464F-9A98-3B4E1CB59815Q35250764-D52ECDC8-F78C-475C-A602-5DA7B322AED1Q35489268-35549452-F622-433E-9078-4AE58BF34909Q36024669-6073BF76-178C-484B-9D13-DC0A9FB3F00EQ36039036-B5EA0EB1-02C2-4F02-B0A4-5410384E71A3Q36318124-2654C2CD-AB18-41F3-897C-4AE1790BE6A6Q37531688-87D4204D-B5DF-49A2-9A88-A2F1B4A605FEQ42584886-CC9FF765-E965-4E77-84DB-353AEFD3A773Q43416448-30BB2288-DAEC-4322-8105-DCDD2ACD400FQ43694069-2212311D-0322-4084-9F67-414CA68A5C24Q43712417-0E8DE38D-FE86-4E2E-AED9-28663EBD792BQ43731163-24A007C9-A78A-4E29-9FB8-893E83C40A58Q43828824-B662550D-F479-4E79-B3D2-D583A17ED37BQ43980182-8AD4A28F-C19A-4355-8B07-297E2D673988Q44021326-72CEE0B5-9A7C-4807-BD77-87B0547BCAE9Q44260515-6645671E-4250-4340-BBDB-DA27786FBC18Q44295732-CB617A05-4EE6-435E-B7FB-0497C8479609Q45038448-C1833306-4820-4872-826A-98D48942531BQ46281670-FAB7322E-7841-4CBE-820C-C69366483B2DQ46381385-784CE511-5AA3-4FA2-8761-D364578ED6E8Q46808127-EA952896-0C7F-4579-AAD1-A96C9138AB9EQ48087211-C504F6EE-2E75-49D2-8794-935F251AB688Q48165227-B7F7D5B7-A901-4791-8D40-FDCBBC2D1CBEQ48230478-94397E15-BE4E-400F-8F74-B49A9587C5EFQ48237215-4FF84CB8-2037-41E5-A284-CC421E76B7B4Q48274556-D34CA30A-2E3B-44EE-A6F7-FE73F5A2124EQ48299696-A027C61A-7D96-4DCA-A07A-5A031BC811EEQ48303693-4D956F88-B1FF-421D-BCB4-B141372FD97FQ48390384-E2A0D671-8A2D-4BDE-91DA-06AE9C8321B6Q48571081-5D697AFD-0433-4549-97D2-51FDBD6E37A5Q48586206-663EBBE0-E2D2-44B0-B296-E429D4001A79Q48665939-AAC400DD-01C2-4AB3-8F82-F0E3E14C3996Q48740501-E586C991-3645-4A02-A7F2-2BED7B631D27Q48844251-212F01BD-BF3D-4588-B1DF-E1208E1D690B
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Isabella Laura Simone
@ast
Isabella Laura Simone
@en
Isabella Laura Simone
@es
Isabella Laura Simone
@nl
Isabella Laura Simone
@sl
type
label
Isabella Laura Simone
@ast
Isabella Laura Simone
@en
Isabella Laura Simone
@es
Isabella Laura Simone
@nl
Isabella Laura Simone
@sl
prefLabel
Isabella Laura Simone
@ast
Isabella Laura Simone
@en
Isabella Laura Simone
@es
Isabella Laura Simone
@nl
Isabella Laura Simone
@sl
P106
P21
P31
P496
0000-0002-7429-3091